Eterna Therapeutics Stock Forecast

Sell candidate since Jul 17, 2026 Loss -15.42%

The Eterna Therapeutics Inc. stock price fell by -15.42% on the last day (Monday, 20th Jul 2026) from $6.42 to $5.43. During the last trading day the stock fluctuated 19.14% from a day low at $5.33 to a day high of $6.35. The price has been going up and down for this period, and there has been a -15.68% loss for the last 2 weeks. Volume has increased on the last day by 127 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 242 thousand shares were bought and sold for approximately $1.31 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.04% during the next 3 months and, with a 90% probability hold a price between $2.92 and $12.48 at the end of this 3-month period.

ERNA Signals & Forecast

There are few to no technical positive signals at the moment. The Eterna Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.19 and $6.76. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, May 15, 2026, and so far it has fallen -60.16%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Eterna Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Eterna Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $5.00 and $4.79. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Eterna Therapeutics Inc. finds support just below today's level at $5.00. If this is broken, then the next support from accumulated volume will be at $4.79 and $4.77.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.02 between high and low, or 19.14%. For the last week, the stock has had daily average volatility of 22.39%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ERNA) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Eterna Therapeutics Inc. to open at $5.70, and during the day (based on 14 day Average True Range), to move between $4.93 and $5.93, which gives a possible trading interval of +/-$1.00 (+/-20.26%) up or down from last closing price. If Eterna Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 20.26% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.00 (7.92%) than the resistance at $5.89 (8.47%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Eterna Therapeutics Inc. stock A Buy?

Eterna Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -6.189 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 21, 2026 - $5.70 ( 5.03%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk